跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,217 条关于
“amylin receptors”
全部
6,217
临床试验
3,933
药物
677
机构
40
资讯
1,567
去年
University of Oklahoma Researchers Unlock Amylin Receptor Mechanisms for Next-Generation Obesity Drugs
2年前
Novo Nordisk's Oral Amycretin Shows Promising Weight Loss in Early Trials
上个月
Cambridge Scientists Solve GIPR Paradox: Distinct Brain Circuits Explain Why Both Activating and Blocking the Same Receptor Drives Weight Loss
去年
AbbVie Enters Obesity Market with $350M Gubra Deal for Novel Amylin Analog
去年
Novo Nordisk's Amycretin Shows Promising Weight Loss in Early Trials
去年
Nxera Pharma Launches Comprehensive Obesity Pipeline with Novel Oral GLP-1 Agonist
去年
Structure Therapeutics Advances Oral Amylin Agonist ACCG-2671 for Obesity Treatment
去年
BrightGene's Dual GLP-1R/GIPR Agonist BGM0504 Shows Superior Efficacy to Semaglutide in Phase 2 Diabetes Trial
去年
Metsera's Monthly Amylin Injection Achieves 8.4% Weight Loss in Phase I Trial
去年
Amylin Analogs Emerge as Key Players in Next-Generation Obesity Treatments
第 1 页,共 157 页
上一页
下一页